Marlene T Morch - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Annals of Clinical and Translational Neurology|July 2, 2026

Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple SclerosisMarlene T Morch, Markus Matilainen, Giulia N Baldrighi, et al.

Journal of Neuroimmunology|January 26, 2025

Targeting extracellular matrix components to attenuate microglia neuroinflammation: A study of fibulin-2 and CSPGs in a model of multiple sclerosisGurleen Randhawa, Maryam Mobarakabadi, Charlotte D'Mello, et al.

Neurology(R) Neuroimmunology & Neuroinflammation|May 29, 2025

Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its ModelsCenxiao Li, Marlene T Morch, Rianne Gorter, et al.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 14, 2026

Investigations of remibrutinib in models pertinent to multiple sclerosisRajiv W Jain, Atefeh Rayatpour, Kathleen Hagen, et al.

Science Translational Medicine|July 15, 2026

Murine autoantigen-specific type 1 regulatory T cells promote oligodendrogenesis through amphiregulin-EGFR signalingRobert Clarke, Atefeh Rayatpour, Josep Garnica, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Annals of Clinical and Translational Neurology|July 2, 2026

Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple SclerosisMarlene T Morch, Markus Matilainen, Giulia N Baldrighi, et al.

Journal of Neuroimmunology|January 26, 2025

Targeting extracellular matrix components to attenuate microglia neuroinflammation: A study of fibulin-2 and CSPGs in a model of multiple sclerosisGurleen Randhawa, Maryam Mobarakabadi, Charlotte D'Mello, et al.

Neurology(R) Neuroimmunology & Neuroinflammation|May 29, 2025

Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its ModelsCenxiao Li, Marlene T Morch, Rianne Gorter, et al.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 14, 2026

Investigations of remibrutinib in models pertinent to multiple sclerosisRajiv W Jain, Atefeh Rayatpour, Kathleen Hagen, et al.

Science Translational Medicine|July 15, 2026

Murine autoantigen-specific type 1 regulatory T cells promote oligodendrogenesis through amphiregulin-EGFR signalingRobert Clarke, Atefeh Rayatpour, Josep Garnica, et al.

Pageof 1